{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:52:56Z","timestamp":1760622776808},"reference-count":27,"publisher":"BMJ","issue":"Supplement 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thorax"],"published-print":{"date-parts":[[1997,4,1]]},"DOI":"10.1136\/thx.52.2008.s60","type":"journal-article","created":{"date-parts":[[2010,1,11]],"date-time":"2010-01-11T19:40:22Z","timestamp":1263238822000},"page":"S60-S63","source":"Crossref","is-referenced-by-count":1,"title":["Nebulisers for patients with HIV infection and AIDS"],"prefix":"10.1136","volume":"52","author":[{"given":"R. F.","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"O'Doherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1164\/ajrccm\/142.3.501","article-title":"Dodging droplet nuclei: reducing the probability of nosocomial tuberculosis transmission in the AIDS era","volume":"142","author":"Nardell, E.A.","year":"1990","unstructured":"Nardell EA. Dodging droplet nuclei: reducing the probability of nosocomial tuberculosis transmission in the AIDS era. Am Rev Respir Dis 1990;142:501\u20133.","journal-title":"Am Rev Respir Dis"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.7326\/0003-4819-111-3-223","article-title":"CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency (HIV) infection","volume":"111","author":"Masur, H.; Ognibene, F.P.; Yarchoan, R.; Shelhamer, J.H.; Baird, B.F.; Travis, W.","year":"1989","unstructured":"Masur H, Ognibene FP, Yarchoan R, Shelhamer JH, Baird BF, Travis W, et al. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency (HIV) infection. Ann Intern Med 1989;111:223\u201331.","journal-title":"Ann Intern Med"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199001183220304","article-title":"The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1","volume":"322","author":"Phair, J.; Munoz, A.; Laslow, R.; Rinaldo, C.R.; Saah, A.","year":"1990","unstructured":"Phair J, Munoz A, Laslow R, Rinaldo CR, Saah A, et al. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. N Engl J Med 1990;322:161\u20135.","journal-title":"N Engl J Med"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/dtb.1994.32212","article-title":"Prevention and treatment of Pneumocystis carinii pneumonia in patients infected with HIV","volume":"32","author":"Miller, R.F.","year":"1994","unstructured":"Miller RF. Prevention and treatment of Pneumocystis carinii pneumonia in patients infected with HIV. Drug Therap Bull 1994;32:12\u201315.","journal-title":"Drug Therap Bull"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJM199212243272604","article-title":"A controlled trial of trimethoprim-sulfamethoxazole or aerosolised pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome","volume":"327","author":"Hardy, W.D.; Feinberg, J.; Finkelstein, D.M.; Detels, R.; Power, M.E.; He, W.; Kaczkac, C.","year":"1992","unstructured":"Hardy WD, Feinberg J, Finkelstein DM, Detels R, Power ME, He W, Kaczkac C, et al. A controlled trial of trimethoprim-sulfamethoxazole or aerosolised pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med 1992;327:1842\u20138.","journal-title":"N Engl J Med"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJM199212243272603","article-title":"A controlled trial of aerosolised pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection","volume":"327","author":"Schneider, M.M.E.; Hoepelman, A.I.M.; Efftinck Shattenkerk, J.K.M.; Nielson, T.I.; der Graafy, Van; Frissen, J.P.H.J.","year":"1992","unstructured":"Schneider MME, Hoepelman AIM, Efftinck Shattenkerk JKM, Nielson TI, Van der Graafy, Frissen JPHJ, et al. A controlled trial of aerosolised pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. N Engl J Med 1992;327:1836\u201341.","journal-title":"N Engl J Med"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJM199305273282102","article-title":"Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection","volume":"328","author":"Girard, P.-M.; Landman, R.; Gaudebout, C.; Olivares, R.; Saimot, A.G.; Jelazko, P.","year":"1993","unstructured":"Girard P-M, Landman R, Gaudebout C, Olivares R, Saimot AG, Jelazko P, et al. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N Engl J Med 1993;328:1514\u201320.","journal-title":"N Engl J Med"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/thx.44.7.565","article-title":"Nebulised pentamidine as treatment for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome","volume":"44","author":"Miller, R.F.; Godfrey-Faussett, P.; Semple, S.J.G.","year":"1989","unstructured":"Miller RF, Godfrey-Faussett P, Semple SJG. Nebulised pentamidine as treatment for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Thorax 1989;44:565\u20139.","journal-title":"Thorax"},{"key":"ref_9","first-page":"1283","article-title":"Differences in relative efficiency of nebulisers for pentamidine administration","volume":"ii:","author":"O\u2019Doherty, M.J.; Thomas, S.; Page, C.; Barlow, D.; Bradbeer, C.; Nunan, T.O.","year":"1988","unstructured":"O\u2019Doherty MJ, Thomas S, Page C, Barlow D, Bradbeer C, Nunan TO, et al. Differences in relative efficiency of nebulisers for pentamidine administration. Lancet 1988; ii:1283\u20136.","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/jac\/27.2.153","article-title":"Nebulised pentamidine as prophylaxis for Pneumocystis carinii pneumonia","volume":"27","author":"Miller, R.; Steel, S.","year":"1991","unstructured":"Miller R, Steel S. Nebulised pentamidine as prophylaxis for Pneumocystis carinii pneumonia. J Antimicrob Chemother 1991;27:153\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/jam.1988.1.113","article-title":"Characteristics of nebulisers used in the treatment of AIDS-related Pneumocystis carinii pneumonia","volume":"1","author":"Smalldone, G.C.; Perry, R.J.; Deutsch, D.G.","year":"1988","unstructured":"Smalldone GC, Perry RJ, Deutsch DG. Characteristics of nebulisers used in the treatment of AIDS-related Pneumocystis carinii pneumonia. J Aerosol Med 1988;1:113\u201326.","journal-title":"J Aerosol Med"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"948","DOI":"10.7326\/0003-4819-114-11-948","article-title":"Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia: a randomised, placebo-controlled study","volume":"114","author":"Montaner, J.S.G.; Lawson, L.M.; Gervais, A.; Hyland, R.H.; Chan, C.K.; Falutz, J.M.","year":"1991","unstructured":"Montaner JSG, Lawson LM, Gervais A, Hyland RH, Chan CK, Falutz JM, et al. Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia: a randomised, placebo-controlled study. Ann Intern Med 1991;114:948\u201353.","journal-title":"Ann Intern Med"},{"key":"ref_13","article-title":"Aerosolised pentamidine","author":"Thomas, S.H.L.; Page, C.M.; O\u2019Doherty, M.J.; Bateman, N.T.","year":"1989","unstructured":"Thomas SHL, Page CM, O\u2019Doherty MJ, Bateman NT. Aerosolised pentamidine. Lancet 1989;ii:1284.","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1183\/09031936.93.04050616","article-title":"Which apparatus for inhaled pentamidine? A comparison of pulmonary deposition via eight nebulisers","volume":"4","author":"Thomas, S.H.L.; O\u2019Doherty, M.J.; Page, C.J.; Nunan, T.O.; Bateman, N.T.","year":"1991","unstructured":"Thomas SHL, O\u2019Doherty MJ, Page CJ, Nunan TO, Bateman NT. Which apparatus for inhaled pentamidine? A comparison of pulmonary deposition via eight nebulisers. Eur Respir J 1991;4:616\u201322.","journal-title":"Eur Respir J"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0954-6111(06)80272-6","article-title":"A comparison of several agents with two delivery systems for the prevention of airway narrowing induced by nebulised pentamidine isethionate","volume":"85","author":"Leigh, T.R.; Wiggins, J.; Gazzard, B.; Collins, J.V.","year":"1991","unstructured":"Leigh TR, Wiggins J, Gazzard B, Collins JV. A comparison of several agents with two delivery systems for the prevention of airway narrowing induced by nebulised pentamidine isethionate. Respir Med 1991;85:527\u201331.","journal-title":"Respir Med"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0140-6736(88)92500-7","article-title":"Reversible bronchoconstriction with nebulised pentamidine","volume":"ii:","author":"Smith, D.E.; Herd, D.; Gazzard, B.","year":"1988","unstructured":"Smith DE, Herd D, Gazzard B. Reversible bronchoconstriction with nebulised pentamidine. Lancet 1988;ii: 905.","journal-title":"Lancet"},{"key":"ref_17","article-title":"Aerosolised pentamidine","author":"Green, S.T.; Nathwani, D.; Christie, P.; Kennedy, D.H.","year":"1989","unstructured":"Green ST, Nathwani D, Christie P, Kennedy DH. Aerosolised pentamidine. Lancet 1989;ii:1284.","journal-title":"Lancet"},{"key":"ref_18","first-page":"1284","article-title":"Aerosolised pentamidine","volume":"ii:","author":"Doll, D.C.","year":"1989","unstructured":"Doll DC. Aerosolised pentamidine. Lancet 1989;ii:1284\u20135.","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1164\/ajrccm\/139.4.1060","article-title":"Selective delivery of pentamidine to the lung by aerosol","volume":"139","author":"Gude, J.K.","year":"1989","unstructured":"Gude JK. Selective delivery of pentamidine to the lung by aerosol. Am Rev Respir Dis 1989;139:1060.","journal-title":"Am Rev Respir Dis"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1378\/chest.99.3.609","article-title":"Pulmonary tolerance of prophylactic aerolised pentamidine in HIV infected patients","volume":"99","author":"Camus, F.; de Picciotto, C.; Lepretre, A.; Landman, R.; Girard, P.M.","year":"1991","unstructured":"Camus F, de Picciotto C, Lepretre A, Landman R, Girard PM. Pulmonary tolerance of prophylactic aerolised pentamidine in HIV infected patients. Chest 1991;99:609\u201312.","journal-title":"Chest"},{"key":"ref_21","first-page":"303","article-title":"Pneumocystis carinii pneumonia","volume":"47","author":"Miller, R.F.; Mitchell, D.M.","year":"1992","unstructured":"Miller RF, Mitchell DM. Pneumocystis carinii pneumonia. Thorax 1992;47:303\u201314.","journal-title":"Thorax"},{"key":"ref_22","first-page":"480","article-title":"Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome","volume":"ii:","author":"Montgomery, A.B.; Luce, J.M.; Turner, J.; Lin, E.T.; Debs, R.J.; Corkery, K.J.","year":"1987","unstructured":"Montgomery AB, Luce JM, Turner J, Lin ET, Debs RJ, Corkery KJ, et al. Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet 1987;ii: 480\u20132.","journal-title":"Lancet"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/jcp.44.10.820","article-title":"Disseminated Pneumocystis carinii infection in AIDS","volume":"44","author":"Coker, R.J.; Clark, D.; Claydon, E.L.; Gompels, M.; Ainsworth, J.G.; Lucas, S.B.","year":"1991","unstructured":"Coker RJ, Clark D, Claydon EL, Gompels M, Ainsworth JG, Lucas SB, et al. Disseminated Pneumocystis carinii infection in AIDS. J Clin Pathol 1991;44:820\u20133.","journal-title":"J Clin Pathol"},{"key":"ref_24","first-page":"1068","article-title":"Pentamidine aerosol versus trimethoprim-sulfamethoxazole for Pneumocystis carinii in acquired immune deficiency syndrome","volume":"151","author":"Montgomery, A.B.; Feigal, D.W.; Sattler, F.; Mason, G.R.; Catanzaro, A.; Edisosn, R.","year":"1995","unstructured":"Montgomery AB, Feigal DW, Sattler F, Mason GR, Catanzaro A, Edisosn R, et al. Pentamidine aerosol versus trimethoprim-sulfamethoxazole for Pneumocystis carinii in acquired immune deficiency syndrome. Am J Respir Crit Care Med 1995;151:1068\u201374.","journal-title":"Am J Respir Crit Care Med"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0163-4453(91)93953-A","article-title":"Sputum induction for the diagnosis of pulmonary disease in HIV positive patients","volume":"23","author":"Miller, R.F.; Kocjan, G.; Buckland, J.; Holton, J.; Malin, A.; Semple, S.J.G.","year":"1991","unstructured":"Miller RF, Kocjan G, Buckland J, Holton J, Malin A, Semple SJG, et al. Sputum induction for the diagnosis of pulmonary disease in HIV positive patients. J Infect 1991; 23:5\u201315.","journal-title":"J Infect"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1183\/09031936.93.06020248","article-title":"Cost effectiveness of the induced sputum technique for the diagnosis of Pneumocystis carinii pneumonia (PCP) in HIV infected patients","volume":"6","author":"Chouaid, C.; Houssef, B.; Poirot, J.L.; Roux, P.; Febrve, M.; Barre, A.","year":"1993","unstructured":"Chouaid C, Houssef B, Poirot JL, Roux P, Febrve M, Barre A, et al. Cost effectiveness of the induced sputum technique for the diagnosis of Pneumocystis carinii pneumonia (PCP) in HIV infected patients. Eur Respir J 1993; 6:248\u201352.","journal-title":"Eur Respir J"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/thx.46.6.449","article-title":"Arterial desaturation in HIV positive patients undergoing sputum induction","volume":"46","author":"Miller, R.F.; Buckland, J.; Semple, S.J.G.","year":"1991","unstructured":"Miller RF, Buckland J, Semple SJG. Arterial desaturation in HIV positive patients undergoing sputum induction. Thorax 1991;46:449\u201351.","journal-title":"Thorax"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thx.52.2008.S60","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T17:09:34Z","timestamp":1711127374000},"score":1,"resource":{"primary":{"URL":"http:\/\/thorax.bmj.com\/cgi\/doi\/10.1136\/thx.52.2008.S60"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,4,1]]},"references-count":27,"journal-issue":{"issue":"Supplement 2","published-print":{"date-parts":[[1997,4,1]]}},"URL":"https:\/\/doi.org\/10.1136\/thx.52.2008.s60","relation":{},"ISSN":["0040-6376"],"issn-type":[{"value":"0040-6376","type":"print"}],"subject":[],"published":{"date-parts":[[1997,4,1]]}}}